Speaker Profile
Ronald L. Ariagno

Ronald L. Ariagno MD, BS

Pediatrics, Medical Education
Stanford, California, United States of America

Connect with the speaker?

Dr. Ariagno is Professor Emeritus of Pediatrics at Stanford University School of Medicine in the Division of Neonatal and Developmental Medicine M. He has been on the faculty at Stanford University since 1975. He received his medical degree from University of Illinois College of Medicine in Chicago and pediatric training at Rush Presbyterian St. Luke’s Hospital in Chicago. His neonatology fellowship was at the University of California San Francisco and Children’s Hospital of San Francisco under Dr. June Brady. He has been on the Executive Committee of the Section on Perinatal Pediatrics (SoPPe) since 1996. He was appointed Chair of the Research Committee and oversees the Marshall Klaus Perinatal Research Award for Fellows in Neonatal–Perinatal Medicine. He was the organizing Chair and first president of the California Association of Neonatologists (CAN) in 1995 and the first American Academy of Pediatrics (AAP) SoPPe District IX Chair of the combined CAN/AAP organization. At Stanford University he chairs one of the Human Subjects in Medical Research Review Committees (2004-).

He is a Certified Simulation Instructor in “Center for Advanced Pediatric Education” (CAPE) directed by L. Halamek, for simulation and neonatal resuscitation and Co-Director of the CAPE Neonatal Resuscitation SimulationTraining Program. From 2013-15 he a Senior Oak Ridge Institute for Science and Education (ORISE) Senior Faculty Fellow in Neonatology in the Office of Pediatric Therapeutics and in the Maternal and Pediatric Section, Center forDrug Evaluation and Research at the FDA to represent neonatology and to help strategize how to facilitate the basic neonatal science research needed and to promote the development of drug and new devices for infants. Currently, he is in second year as Intergovernmental Personnel Act Agreement with Stanford University as a neonatology consult at the US Food and Drug Administration in the Office of Pediatric Therapeutics. He also Chairs a Task Force for Neonatal Perinatal Therapeutic Development for the Section on Neonatal-Perinatal Medicine at the American Academy of Pediatrics.

EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)